Chemotherapy at the End of Life: Factors of Prescription

J Palliat Med. 2015 Aug;18(8):658-9. doi: 10.1089/jpm.2015.0134. Epub 2015 Jun 18.

Authors

Vincent Massard¹, Julia Salleron², Ivan Krakowski^{1

3}, Thierry Conroy¹, Béatrice Weber¹

Affiliations

¹ 1 Department of Medical Oncology, Institut de Cancérologie de Lorraine , Vandoeuvre-lès-Nancy, France .
² 2 Unit of Biostatistics, Institut de Cancérologie de Lorraine , Vandoeuvre-lès-Nancy, France .
³ 3 Palliative Care Department, Institut de Cancérologie de Lorraine , Vandoeuvre-lès-Nancy, France .

PMID: 26087120
DOI: 10.1089/jpm.2015.0134

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / therapeutic use*
Decision Making
Female
France / epidemiology
Humans
Male
Neoplasms / drug therapy*
Neoplasms / mortality
Palliative Care*
Survival Rate
Terminal Care*

Substances

Antineoplastic Agents